Profile
John A. Bardi served as Vice President at Bristol-Myers Squibb Pharma Research Labs LLC, Vice President-Market Access & Policy Advocacy at Otsuka America Pharmaceutical, Inc., and SVP-Market Access, Policy & Government Affairs at Intra-Cellular Therapies, Inc. Mr. Bardi completed graduate studies at George Washington University and undergraduate studies at West Chester University of Pennsylvania.
Former positions of John A. Bardi
| Companies | Position | End |
|---|---|---|
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | General Counsel | - |
Bristol-Myers Squibb Pharma Research Labs LLC
Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Corporate Officer/Principal | - |
| INTRA-CELLULAR THERAPIES, INC. | General Counsel | - |
Training of John A. Bardi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Pharma Research Labs LLC
Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Commercial Services |
West Chester University of Pennsylvania
West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
- Stock Market
- Insiders
- John A. Bardi
















